383 related articles for article (PubMed ID: 18209608)
21. Botulinum toxin-a in children with congenital spastic hemiplegia does not improve upper extremity motor-related function over rehabilitation alone: a randomized controlled trial.
Rameckers EA; Speth LA; Duysens J; Vles JS; Smits-Engelsman BC
Neurorehabil Neural Repair; 2009; 23(3):218-25. PubMed ID: 19106252
[TBL] [Abstract][Full Text] [Related]
22. Botulinum A toxin for treatment of lower limb spasticity in cerebral palsy: gait analysis in 49 patients.
Papadonikolakis AS; Vekris MD; Korompilias AV; Kostas JP; Ristanis SE; Soucacos PN
Acta Orthop Scand; 2003 Dec; 74(6):749-55. PubMed ID: 14763710
[TBL] [Abstract][Full Text] [Related]
23. Botulinum toxin type-A and plaster cast treatment in children with upper brachial plexus palsy.
Basciani M; Intiso D
Pediatr Rehabil; 2006; 9(2):165-70. PubMed ID: 16449076
[TBL] [Abstract][Full Text] [Related]
24. Assessment protocol for serial casting after botulinum toxin a injections to treat equinus gait.
Kelly B; MacKay-Lyons MJ; Berryman S; Hyndman J; Wood E
Pediatr Phys Ther; 2008; 20(3):233-41. PubMed ID: 18703960
[TBL] [Abstract][Full Text] [Related]
25. Botulinum toxin type A injections can be an effective treatment for pain in children with hip spasms and cerebral palsy.
Lundy CT; Doherty GM; Fairhurst CB
Dev Med Child Neurol; 2009 Sep; 51(9):705-10. PubMed ID: 19459910
[TBL] [Abstract][Full Text] [Related]
26. Cortical somatosensory evoked potentials and spasticity assessment after botulinum toxin type A injection in children with cerebral palsy.
Boćkowski L; Okurowska-Zawada B; Sobaniec W; Kułak W; Sendrowski K
Adv Med Sci; 2007; 52 Suppl 1():171-5. PubMed ID: 18229658
[TBL] [Abstract][Full Text] [Related]
27. Casting, taping or stretching after botulinum toxin type A for spastic equinus foot: a single-blind randomized trial on adult stroke patients.
Carda S; Invernizzi M; Baricich A; Cisari C
Clin Rehabil; 2011 Dec; 25(12):1119-27. PubMed ID: 21729974
[TBL] [Abstract][Full Text] [Related]
28. Functional outcome following Botulinum toxin A injection to reduce spastic equinus in adults with traumatic brain injury.
Fock J; Galea MP; Stillman BC; Rawicki B; Clark M
Brain Inj; 2004 Jan; 18(1):57-63. PubMed ID: 14660236
[TBL] [Abstract][Full Text] [Related]
29. Casting Protocols Following BoNT-A Injections to Treat Spastic Hypertonia of the Triceps Surae in Children with Cerebral Palsy and Equinus Gait: A Randomized Controlled Trial.
Kelly B; MacKay-Lyons M; Berryman S; Hyndman J; Wood E
Phys Occup Ther Pediatr; 2019; 39(1):77-93. PubMed ID: 29771161
[TBL] [Abstract][Full Text] [Related]
30. Longitudinal examination of health outcomes associated with botulinum toxin use in children with cerebral palsy.
Balkrishnan R; Manuel JC; Smith BP; Camacho FT; Koman LA
J Surg Orthop Adv; 2004; 13(2):76-80. PubMed ID: 15281403
[TBL] [Abstract][Full Text] [Related]
31. [Botulinum toxin in spastic infantile cerebral palsy: results in 27 cases during one year].
Sánchez-Carpintero R; Narbona J
Rev Neurol; 1997 Apr; 25(140):531-5. PubMed ID: 9172911
[TBL] [Abstract][Full Text] [Related]
32. Prospective study examining remote effects of botulinum toxin a in children with cerebral palsy.
Crowner BE; Racette BA
Pediatr Neurol; 2008 Oct; 39(4):253-8. PubMed ID: 18805363
[TBL] [Abstract][Full Text] [Related]
33. Effect of multilevel botulinum toxin a and comprehensive rehabilitation on gait in cerebral palsy.
Scholtes VA; Dallmeijer AJ; Knol DL; Speth LA; Maathuis CG; Jongerius PH; Becher JG
Pediatr Neurol; 2007 Jan; 36(1):30-9. PubMed ID: 17162194
[TBL] [Abstract][Full Text] [Related]
34. Spread of botulinum neurotoxin type a at standard doses is inherent to the successful treatment of spastic equinus foot in cerebral palsy: short-term neurophysiological and clinical study.
Frasson E; Dall'ora E; Bordignon M; Brigo F; Tocco P; Primon D; Didonè G; Vicentini S; Fiaschi A; Bertolasi L
J Child Neurol; 2012 May; 27(5):587-93. PubMed ID: 22114218
[TBL] [Abstract][Full Text] [Related]
35. Botulinum toxin type A in the management of equinus in children with cerebral palsy: an evidence-based economic evaluation.
Houltram J; Noble I; Boyd RN; Corry I; Flett P; Graham HK
Eur J Neurol; 2001 Nov; 8 Suppl 5():194-202. PubMed ID: 11851748
[TBL] [Abstract][Full Text] [Related]
36. Treating spastic equinus foot from cerebral palsy with botulinum toxin type A: what factors influence the results?: an analysis of 189 consecutive cases.
Pascual-Pascual SI; Pascual-Castroviejo I; Ruiz PJ
Am J Phys Med Rehabil; 2011 Jul; 90(7):554-63. PubMed ID: 21765274
[TBL] [Abstract][Full Text] [Related]
37. [Botulin toxin as treatment for spasticity and dystonia in infantile cerebral paralysis].
Aguilar-Rebolledo F; Hernández-Sánchez J; Rayo-Mares D; Soriano-Fonseca F; García-Muñoz L; Ruiz-Ponce J; Garrido-Ramírez E
Gac Med Mex; 2001; 137(5):403-11. PubMed ID: 11692809
[TBL] [Abstract][Full Text] [Related]
38. Botulinum toxin (Dysport) treatment of the spastic gastrocnemius muscle in children with cerebral palsy: a randomized trial comparing two injection volumes.
Hu GC; Chuang YC; Liu JP; Chien KL; Chen YM; Chen YF
Clin Rehabil; 2009 Jan; 23(1):64-71. PubMed ID: 19114438
[TBL] [Abstract][Full Text] [Related]
39. Botulinum toxin and cerebral palsy: time for reflection?
Gough M; Fairhurst C; Shortland AP
Dev Med Child Neurol; 2005 Oct; 47(10):709-12. PubMed ID: 16174320
[TBL] [Abstract][Full Text] [Related]
40. [Botulinum toxin Type A. Indications and results].
Póo P; López-Casas JA; Galván-Manso M; Aquino-Fariña L; Terricabras-Carol L; Campistol J
Rev Neurol; 2003 Jul 1-15; 37(1):74-80. PubMed ID: 12861515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
